Avantor, Inc. (AVTR)Healthcare | Medical Instruments & Supplies | Radnor, United States | NYSE
16.09 USD
+0.39
(2.484%)
⇧
(Oct. 15, 2026, 4 p.m.
EDT)
After hours: 15.96 -0.13 (-0.130%) ⇩ (Oct. 15, 2026, 6 p.m. EDT) |
Hot Take ↕ | Oct. 10, 2026, 6:47 a.m. EDT
The investment case for Avantor is currently fractured by deteriorating fundamentals and a lack of shareholder returns. The company is posting negative earnings growth and a trailing EPS of -$0.84, while the balance sheet carries significant debt relative to equity. Crucially, the multi-year price trajectory shows a net decline of nearly 5% over six years, with the most recent annual return being sharply negative; this persistent underperformance suggests the market views the current valuation as insufficient to offset the business risks. Compounding this weakness, the company has not paid a dividend in five years, offering no income buffer to investors. While the stock has recently rallied on improved sales outlooks and analyst upgrades, the options market tells a different story: traders are aggressively buying deep out-of-the-money puts, betting on a continuation of the downtrend. Until the earnings turnaround is sustained and the balance sheet strengthens, the risk-reward profile remains skewed toward caution. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.223185 |
| AutoETS | 0.226233 |
| AutoARIMA | 0.226235 |
| AutoTheta | 0.257379 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 3.73 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.002 |
| Excess Kurtosis | 0.80 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 65.678 |
| Revenue per Share | 9.679 |
| Market Cap | 10,882,614,272 |
| Forward P/E | 18.34 |
| Beta | 0.94 |
| Profit Margins | -8.81% |
| Website | https://www.avantorsciences.com |
As of Oct. 10, 2026, 6:47 a.m. EDT: Speculators are positioning heavily for downside protection, evidenced by massive open interest in deep out-of-the-money puts (strikes 8.0, 10.0, 12.0) expiring late 2027 and early 2028. While there is some volume in calls at strikes 17.0 and 22.0, the overwhelming capital allocation is in put writing and buying, suggesting a consensus view of continued volatility or further decline rather than a robust recovery.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.07755661 |
| Address1 | Radnor Corporate Center |
| Address2 | Building One Suite 200 100 Matsonford Road |
| All Time High | 44.37 |
| All Time Low | 6.655 |
| Ask | 16.09 |
| Ask Size | 1,600 |
| Audit Risk | 1 |
| Average Analyst Rating | 2.8 - Hold |
| Average Daily Volume10 Day | 7,727,840 |
| Average Daily Volume3 Month | 9,262,331 |
| Average Volume | 9,262,331 |
| Average Volume10Days | 7,727,840 |
| Beta | 0.935 |
| Bid | 16.19 |
| Bid Size | 2,700 |
| Board Risk | 3 |
| Book Value | 8.323 |
| City | Radnor |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 4 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 16.09 |
| Current Ratio | 1.782 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 16.26 |
| Day Low | 15.7 |
| Debt To Equity | 65.678 |
| Display Name | Avantor |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,793,217,600 |
| Earnings Call Timestamp Start | 1,793,217,600 |
| Earnings Growth | -0.374 |
| Earnings Quarterly Growth | -0.411 |
| Earnings Timestamp | 1,793,190,600 |
| Earnings Timestamp End | 1,793,190,600 |
| Earnings Timestamp Start | 1,793,190,600 |
| Ebitda | 943,699,968 |
| Ebitda Margins | 0.14383 |
| Enterprise To Ebitda | 15.125 |
| Enterprise To Revenue | 2.175 |
| Enterprise Value | 14,273,613,824 |
| Eps Current Year | 0.81289 |
| Eps Forward | 0.87733 |
| Eps Trailing Twelve Months | -0.84 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 20 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 14.7534 |
| Fifty Day Average Change | 1.3366003 |
| Fifty Day Average Change Percent | 0.09059609 |
| Fifty Two Week Change Percent | 7.755661 |
| Fifty Two Week High | 16.375 |
| Fifty Two Week High Change | -0.28499985 |
| Fifty Two Week High Change Percent | -0.017404571 |
| Fifty Two Week Low | 7.265 |
| Fifty Two Week Low Change | 8.825001 |
| Fifty Two Week Low Change Percent | 1.2147282 |
| Fifty Two Week Range | 7.265 - 16.375 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,558,099,800,000 |
| Float Shares | 657,806,317 |
| Forward Eps | 0.87733 |
| Forward P E | 18.339735 |
| Free Cashflow | 450,337,504 |
| Full Exchange Name | NYSE |
| Full Time Employees | 13,500 |
| Fullday Change | 0.26000023 |
| Fullday Change Percent | 1.6560525 |
| Fullday Price | 16.09 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.31825 |
| Gross Profits | 2,088,099,968 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01528 |
| Held Percent Institutions | 1.05724 |
| Implied Shares Outstanding | 676,358,840 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania. |
| Long Name | Avantor, Inc. |
| Market | us_market |
| Market Cap | 10,882,614,272 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_403055588 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -578,000,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 9,983,056,478 |
| Number Of Analyst Opinions | 14 |
| Open | 15.83 |
| Operating Cashflow | 597,000,000 |
| Operating Margins | 0.07162 |
| Overall Risk | 1 |
| Payout Ratio | 0.0 |
| Phone | 610 386 1700 |
| Post Market Change | -0.13000011 |
| Post Market Change Percent | -0.807956 |
| Post Market Price | 15.96 |
| Post Market Time | 1,792,101,605 |
| Previous Close | 15.7 |
| Price Eps Current Year | 19.793577 |
| Price Hint | 2 |
| Price To Book | 1.9331971 |
| Price To Sales Trailing12 Months | 1.6586571 |
| Profit Margins | -0.08809 |
| Quick Ratio | 1.046 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 2.8125 |
| Region | US |
| Regular Market Change | 0.39 |
| Regular Market Change Percent | 2.48408 |
| Regular Market Day High | 16.26 |
| Regular Market Day Low | 15.7 |
| Regular Market Day Range | 15.7 - 16.26 |
| Regular Market Open | 15.83 |
| Regular Market Previous Close | 15.7 |
| Regular Market Price | 16.09 |
| Regular Market Time | 1,792,094,402 |
| Regular Market Volume | 5,967,875 |
| Return On Assets | 0.02694 |
| Return On Equity | -0.09701 |
| Revenue Growth | 0.005 |
| Revenue Per Share | 9.679 |
| Sand P52 Week Change | 0.16440773 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 1 |
| Shares Outstanding | 676,358,840 |
| Shares Percent Shares Out | 0.0582 |
| Shares Short | 39,348,974 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 50,213,671 |
| Short Name | Avantor, Inc. |
| Short Percent Of Float | 0.0706 |
| Short Ratio | 4.47 |
| Source Interval | 15 |
| State | PA |
| Symbol | AVTR |
| Target High Price | 19.0 |
| Target Low Price | 13.0 |
| Target Mean Price | 15.46429 |
| Target Median Price | 15.0 |
| Total Cash | 306,800,000 |
| Total Cash Per Share | 0.454 |
| Total Debt | 3,697,799,936 |
| Total Revenue | 6,561,099,776 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.84 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 10.90825 |
| Two Hundred Day Average Change | 5.1817503 |
| Two Hundred Day Average Change Percent | 0.4750304 |
| Type Disp | Equity |
| Volume | 5,967,875 |
| Website | https://www.avantorsciences.com |
| Zip | 19,087 |